Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1990 1
1995 1
1997 1
2004 2
2006 2
2007 3
2008 2
2009 1
2010 1
2011 1
2012 4
2013 4
2014 6
2015 2
2016 6
2017 3
2018 9
2019 9
2020 9
2021 7
2022 9
2023 9
2024 14
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.
Castillo JJ, Guerrero-Garcia T, Baldini F, Tchernonog E, Cartron G, Ninkovic S, Cwynarski K, Dierickx D, Tousseyn T, Lansigan F, Linnik Y, Mogollon R, Navarro JT, Olszewski AJ, Reagan JL, Fedele P, Gilbertson M, Grigoriadis G, Bibas M. Castillo JJ, et al. Among authors: fedele p. Br J Haematol. 2019 Feb;184(4):679-682. doi: 10.1111/bjh.15156. Epub 2018 Mar 12. Br J Haematol. 2019. PMID: 29527667 Clinical Trial. No abstract available.
Unraveling the diversity and functions of tissue-resident plasma cells.
Tellier J, Tarasova I, Nie J, Smillie CS, Fedele PL, Cao WHJ, Groom JR, Belz GT, Bhattacharya D, Smyth GK, Nutt SL. Tellier J, et al. Among authors: fedele pl. Nat Immunol. 2024 Feb;25(2):330-342. doi: 10.1038/s41590-023-01712-w. Epub 2024 Jan 3. Nat Immunol. 2024. PMID: 38172260
Targeted Therapy in Acute Lymphoblastic Leukaemia.
Salvaris R, Fedele PL. Salvaris R, et al. Among authors: fedele pl. J Pers Med. 2021 Jul 25;11(8):715. doi: 10.3390/jpm11080715. J Pers Med. 2021. PMID: 34442359 Free PMC article. Review.
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan.
Fabi A, Rossi A, Caputo R, Pisegna S, Scagnoli S, Pantano F, D'Auria G, Fedele P, Fabbri A, Vernieri C, Palleschi M, Carbognin L, Ferretti G, Di Monte E, Paris I, Pavese F, Garrone O, Franco A, De Laurentiis M, Franceschini G, Scambia G, Giannarelli D, Masetti R, Botticelli A. Fabi A, et al. Among authors: fedele p. NPJ Precis Oncol. 2025 Jan 22;9(1):22. doi: 10.1038/s41698-025-00801-3. NPJ Precis Oncol. 2025. PMID: 39843642 Free PMC article.
Indolent lymphoma: addressing the needs of survivors.
Fedele PL, Opat S. Fedele PL, et al. Leuk Lymphoma. 2025 Jun;66(6):1021-1035. doi: 10.1080/10428194.2025.2456970. Epub 2025 Jan 28. Leuk Lymphoma. 2025. PMID: 39876569 Free article. Review.
Immunotherapy and Pancreatic Cancer: A Lost Challenge?
Laface C, Memeo R, Maselli FM, Santoro AN, Iaia ML, Ambrogio F, Laterza M, Cazzato G, Guarini C, De Santis P, Perrone M, Fedele P. Laface C, et al. Among authors: fedele p. Life (Basel). 2023 Jun 30;13(7):1482. doi: 10.3390/life13071482. Life (Basel). 2023. PMID: 37511856 Free PMC article. Review.
105 results